Erhaltungstherapie für Patienten mit FMS-ähnlicher Tyrosinkinase-3-Intrinib-Intratandem-Repeat-akuter myeloischer Leukämie mit Giretinib: Eine Phase-2-Studie – Wiley & Sons
Erhaltungstherapie für Patienten mit akuter myeloischer Leukämie mit FMS-ähnlicher Tyrosinkinase 3-internen Tandem-Repeat-Mutation unter Verwendung von Giretinib, einem FMS-ähnlich…
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
Soalan Lazim
Which products are related to this article?
No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
